NCT03367156 2025-11-12
Dexamethasone in Controlling Dyspnea in Patients With Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
12 trialsNCT01832402 2023-06-08
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02932332 2023-04-21
High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02357134 2022-12-07
High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer
M.D. Anderson Cancer Center
Phase 2 Unknown
NCT01670097 2021-02-17
Dexamethasone Dyspnea Study
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01856114 2020-09-16
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01880528 2020-01-02
Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer
Mayo Clinic
Phase 2 Completed
NCT00934128 2016-03-02
High Flow Oxygen and Bilevel Airway Pressure for Persistent Dyspnea in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01172925 2015-05-27
TIDAL
McMaster University
Phase 2 Unknown
NCT01687751 2015-05-25
Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients
Fraser Health
Phase 2 Withdrawn
NCT01518140 2013-08-13
BiPAP-Vapotherm RCT
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT01123902 2010-05-14
Effectiveness of a Hand-held Fan for Breathlessness
King's College London
Phase 2 Completed